CYBN (Cybin) מכפיל שווי פעילות להכנסות

Cybin Inc. (CYBN) - לוגו תאגידי

Cybin Inc. is focusing on completing final clinical trials and securing patent protection for its innovative depression therapy. The process is being accelerated through bioinformatic modeling and automated molecular screening. Since success depends on medicine rather than economics, the enterprise value-to-revenue dynamic serves as an objective indicator, where the parameter has stabilized at 0.00.

Cybin Inc (CYBN) - מכפיל EV/Sales מ-23.11.2025 עד 05.01.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור Cybin (CYBN)

- שווי שוק ותחזית יעד של אנליסטים:
- מדדי הערכת שווי שוק של העסק:
הערכת שווי פונדמנטלית של החברה:CYBN (Cybin Corp)
מוצרים מוגמרים של cybin.com

Investors assess fundamental capital risks through the ratio of business value to operating income. For Cybin Inc. (CYBN), the completion timelines for psychedelic clinical trials are critical, as commercial revenue is currently nonexistent. The EV/Sales metric combines market capitalization and net debt, benchmarking them against sales volume. The stability of this chart reflects market expectations for future products, while the current smooth trajectory signals that speculative hopes are fully priced in.